LOIP
IDXX icon

Live Oak Investment Partners’s Idexx Laboratories IDXX Stock Holding History

Live Oak Investment Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Buy
2,302
+198
+9% +$127K 0.76% 37
2025
Q4 		$1.42M Buy
2,104
+508
+32% +$346K 0.87% 35
2025
Q3 		$1.02M Buy
1,596
+232
+17% +$141K 0.68% 37
2025
Q2 		$732K Buy
+1,364
New +$652K 0.56% 48

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Live Oak Investment Partners's IDXX Position: Q1 2026 in Review

Live Oak Investment Partners increased its Idexx Laboratories (IDXX) stake by 9.4% in Q1 2026, buying an estimated $127K and bringing the position to 2,302 shares worth $1.29M. The position accounts for 0.76% of the portfolio, ranked #37.

Live Oak Investment Partners first reported a position in IDXX in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.42M in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Live Oak Investment Partners held 2,302 shares of Idexx Laboratories worth $1.29M as of Q1 2026.
  • Live Oak Investment Partners bought 198 Idexx Laboratories shares in Q1 2026, an estimated $127K.
  • Idexx Laboratories made up 0.76% of Live Oak Investment Partners's portfolio in Q1 2026, its #37 holding.
  • Live Oak Investment Partners first reported a position in Idexx Laboratories in Q2 2025 and has held it in 4 quarters since.
  • Live Oak Investment Partners's Idexx Laboratories position peaked at $1.42M in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Live Oak Investment Partners's 13F filing for Q1 2026, filed 29 Apr 2026.